Table 3.
Postoperative data n (%)
| < 5-yr survival | > 5-yr survival | P value | |
| Hospital stay | 13 | 11.78 | 0.33 |
| Bile leakage | 75 (35.88) | 7 (20.0) | 0.08 |
| Wound infection | 50 (23.9) | 6 (17.6) | 0.39 |
| Early LCF | 38 (18.18) | 1 (2.9) | 0.023 |
| Collection | 38 (18.18) | 6 (17.6) | 0.94 |
| Bleeding and fistula | 13 (6.2) | 1 (2.9) | 0.42 |
| Lymph node metastasis | 81 (41.8) | 6 (17.6) | 0.008 |
| Histological grade | 0.033 | ||
| Well differentiated | 78 (37.32) | 20 (58.82) | |
| Moderately differentiated | 83 (39.71) | 11 (32.35) | |
| Poorly differentiated | 48 (23.0) | 3 (8.82) | |
| Safety margin | < 0.0001 | ||
| R0 | 93 (44.5%) | 28 (82.35) | |
| R1 | 116 (55.5) | 6 (17.6) | |
| Recurrence | 0.88 | ||
| Hepatic recurrence | 51 (24.4) | 8 (23.52) | |
| Local recurrence | 27 (12.9) | 6 (17.64) | |
| Late LCF | 51 (51.5) | 8 (33.3) | 0.11 |
LCF: Liver cell failure.